Omega Therapeutics announced the election of Richard N. Kender to its Board of Directors following its annual meeting of stockholders. Mr. Kender’s industry knowledge and proven expertise in corporate finance and business development spanning both large pharmaceutical and emerging biotech companies will be instrumental in supporting the Company’s business objectives.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMGA:
- Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors
- Omega Therapeutics initiated with an Outperform at Raymond James
- Omega Therapeutics Appoints New Chief Business Officer
- Omega Therapeutics To Participate In Two Upcoming Investor Conferences
- Omega Therapeutics appoints Certel as Chief Business Officer